This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Oncotherm medical devices are produced by Oncotherm Ltd. and used for cancer treatment.
Methodology edit
The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the oncothermia treatment.[1] The tumor tissue has lower impedance than the surrounding tissues,[citation needed] so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary.[2]
Company edit
Oncotherm Ltd. was founded in 1988 by Prof. Dr. András Szász[3] in Hungary. In 2002, it received investment from a German company and was reorganized as a German-Hungarian company consisting of Oncotherm Hungary Ltd[4] and Oncotherm GmbH.[5]
Medical devices edit
Their main products are the Oncotherm EHY-2000[6] and the Oncotherm EHY-2030,[7] hyperthermia devices using the thermoelectric effects of electrical fields.
More than 450 devices have been placed into operation, mostly in Germany and South Korea, and performed over 400,000 treatments.[8] The devices are not approved by the U.S. Food and Drug Administration.[citation needed]
References edit
- ^ Szasz A (2007). "Hyperthermia, a modality in the wings". J Cancer Res Ther. 3 (1): 56–66. doi:10.4103/0973-1482.31976. PMID 17998724.
- ^ "Oncothermia method | Oncotherm". oncotherm.com. Retrieved 2020-02-25.
- ^ aiadmin. "Prof. András Szász". Retrieved 2020-02-29.
- ^ "OncoTherm Kft céginformáció, cégkivonat, cégmásolat". i.creditonline.hu. Retrieved 2020-02-29.
- ^ "Contact Us | Oncotherm". oncotherm.com. Retrieved 2020-02-29.
- ^ "EHY-2000plus | Oncotherm". oncotherm.com. Retrieved 2020-02-29.
- ^ "EHY-2030 | Oncotherm".
- ^ Oncotherm Official site
 | This oncology article is a stub. You can help Wikipedia by expanding it. |